{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T06:36:00Z","timestamp":1780814160459,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81971645"],"award-info":[{"award-number":["81971645"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aims to establish a predictive model on the basis of <jats:sup>18<\/jats:sup>F-FDG PET\/CT for diagnosing the nature of pleural effusion (PE) in patients with lung adenocarcinoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Lung adenocarcinoma patients with PE who underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT were collected and divided into training and test cohorts. PET\/CT parameters and clinical information in the training cohort were collected to estimate the independent predictive factors of malignant pleural effusion (MPE) and to establish a predictive model. This model was then applied to the test cohort to evaluate the diagnostic efficacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 413 lung adenocarcinoma patients with PE were enrolled in this study, including 245 patients with MPE and 168 patients with benign PE (BPE). The patients were divided into training (289 patients) and test (124 patients) cohorts. CEA, SUVmax of tumor and attachment to the pleura, obstructive atelectasis or pneumonia, SUVmax of pleura, and SUVmax of PE were identified as independent significant factors of MPE and were used to construct a predictive model, which was graphically represented as a nomogram. This predictive model showed good discrimination with the area under the curve (AUC) of 0.970 (95% CI 0.954\u20130.986) and good calibration. Application of the nomogram in the test cohort still gave good discrimination with AUC of 0.979 (95% CI 0.961\u20130.998) and good calibration. Decision curve analysis demonstrated that this nomogram was clinically useful.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our predictive model based on <jats:sup>18<\/jats:sup>F-FDG PET\/CT showed good diagnostic performance for PE, which was helpful to differentiate MPE from BPE in patients with lung adenocarcinoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13550-021-00850-2","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T20:20:01Z","timestamp":1634329201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on 18F-FDG PET\/CT"],"prefix":"10.1186","volume":"11","author":[{"given":"Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9479-132X","authenticated-orcid":false,"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"issue":"Suppl 2","key":"850_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/thx.2010.136994","volume":"65","author":"ME Roberts","year":"2010","unstructured":"Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):32\u201340.","journal-title":"Thorax"},{"key":"850_CR2","first-page":"177","volume":"51","author":"PF Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez PF. Diagnosis and treatment of malignant pleural mesothelioma. Arch Bronconeumol. 2015;51:177\u201384.","journal-title":"Arch Bronconeumol"},{"issue":"Suppl 2","key":"850_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/thx.58.suppl_2.ii29","volume":"58","author":"G Antunes","year":"2003","unstructured":"Antunes G, Neville E, Duffy J, Ali N. BTS guidelines for the management of malignant pleural effusions. Thorax. 2003;58(Suppl 2):29\u201338.","journal-title":"Thorax"},{"key":"850_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/01.mnm.0000243366.96012.c0","volume":"27","author":"BC Duysinx","year":"2006","unstructured":"Duysinx BC, Larock M-P, Nguyen D, Corhay J-L, Bury T, Hustinx R, et al. 18F-FDG PET imaging in assessing exudative pleural effusions. Nucl Med Commun. 2006;27:971\u20136.","journal-title":"Nucl Med Commun"},{"key":"850_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s10147-016-1073-y","volume":"22","author":"M Feng","year":"2017","unstructured":"Feng M, Zhu J, Liang L, Zeng N, Wu Y, Wan C, et al. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis. Int J Clin Oncol. 2017;22:283\u201390.","journal-title":"Int J Clin Oncol"},{"key":"850_CR6","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.21873\/anticanres.13039","volume":"38","author":"H Tamiya","year":"2018","unstructured":"Tamiya H, Mitani A, Saito A, Ishimori T, Saito M, Isago H, et al. Exosomal microRNA expression profiling in patients with lung adenocarcinoma-associated malignant pleural effusion. Anticancer Res. 2018;38:6707\u201314.","journal-title":"Anticancer Res"},{"key":"850_CR7","first-page":"1021","volume":"7","author":"T Agalioti","year":"2015","unstructured":"Agalioti T, Giannou AD, Stathopoulos GT. Pleural involvement in lung cancer. J Thorac Dis. 2015;7:1021\u201330.","journal-title":"J Thorac Dis"},{"key":"850_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1378\/chest.14-0013","volume":"147","author":"JM Porcel","year":"2015","unstructured":"Porcel JM, Pardina M, Bielsa S, Gonz\u00e1lez A, Light RW. Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions. Chest. 2015;147:513\u20139.","journal-title":"Chest"},{"key":"850_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1148\/radiol.2015142388","volume":"278","author":"J-S Ryu","year":"2016","unstructured":"Ryu J-S, Lim JH, Lee JM, Kim WC, Lee K-H, Memon A, et al. Minimal pleural effusion in small cell lung cancer: proportion, mechanisms, and prognostic effect. Radiology. 2016;278:593\u2013600.","journal-title":"Radiology"},{"key":"850_CR10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1200\/JCO.2013.50.5453","volume":"32","author":"J-S Ryu","year":"2014","unstructured":"Ryu J-S, Ryu HJ, Lee S-N, Memon A, Lee S-K, Nam H-S, et al. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer. J Clin Oncol. 2014;32:960\u20137.","journal-title":"J Clin Oncol"},{"key":"850_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1378\/chest.14-0820","volume":"147","author":"JM Porcel","year":"2015","unstructured":"Porcel JM, Hern\u00e1ndez P, Mart\u00ednez-Alonso M, Bielsa S, Salud A. Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis. Chest. 2015;147:502\u201312.","journal-title":"Chest"},{"key":"850_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1440-1843.2008.01306.x","volume":"13","author":"JE Heffner","year":"2008","unstructured":"Heffner JE. Diagnosis and management of malignant pleural effusions. Respirology. 2008;13:5\u201320.","journal-title":"Respirology"},{"key":"850_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12149-012-0575-6","volume":"26","author":"M-Y Jung","year":"2012","unstructured":"Jung M-Y, Chong A, Seon HJ, Choi S, Kim Y-H, Shin SS, et al. Indeterminate pleural metastasis on contrast-enhanced chest CT in non-small cell lung cancer: improved differential diagnosis with (18)F-FDG PET\/CT. Ann Nucl Med. 2012;26:327\u201336.","journal-title":"Ann Nucl Med"},{"key":"850_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/thx.52.2.187","volume":"52","author":"T Bury","year":"1997","unstructured":"Bury T, Paulus P, Dowlati A, Corhay JL, Rigo P, Radermecker MF. Evaluation of pleural diseases with FDG-PET imaging: preliminary report. Thorax. 1997;52:187\u20139.","journal-title":"Thorax"},{"key":"850_CR15","doi-asserted-by":"publisher","first-page":"e1010","DOI":"10.1097\/MD.0000000000001010","volume":"94","author":"R Nakajima","year":"2015","unstructured":"Nakajima R, Abe K, Sakai S. Diagnostic ability of FDG-PET\/CT in the detection of malignant pleural effusion. Medicine (Baltimore). 2015;94:e1010.","journal-title":"Medicine (Baltimore)"},{"key":"850_CR16","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00259-019-04287-7","volume":"46","author":"M-F Yang","year":"2019","unstructured":"Yang M-F, Tong Z-H, Wang Z, Zhang Y-Y, Xu L-L, Wang X-J, et al. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion. Eur J Nucl Med Mol Imaging. 2019;46:1457\u201367.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"850_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2214\/ajr.154.3.2106209","volume":"154","author":"AN Leung","year":"1990","unstructured":"Leung AN, M\u00fcller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol. 1990;154:487\u201392.","journal-title":"AJR Am J Roentgenol"},{"key":"850_CR18","doi-asserted-by":"publisher","first-page":"e0161764","DOI":"10.1371\/journal.pone.0161764","volume":"11","author":"Y Sun","year":"2016","unstructured":"Sun Y, Yu H, Ma J, Lu P. The role of 18F-FDG PET\/CT integrated imaging in distinguishing malignant from benign pleural effusion. PLoS ONE. 2016;11:e0161764.","journal-title":"PLoS ONE"},{"key":"850_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13014-015-0343-6","volume":"10","author":"T Yamamoto","year":"2015","unstructured":"Yamamoto T, Kadoya N, Shirata Y, Koto M, Sato K, Matsushita H, et al. Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy. Radiat Oncol. 2015;10:35.","journal-title":"Radiat Oncol"},{"key":"850_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000329612","volume":"34","author":"BS Kim","year":"2011","unstructured":"Kim BS, Kim IJ, Kim S-J, Pak K, Kim K. Predictive value of F-18 FDG PET\/CT for malignant pleural effusion in non-small cell lung cancer patients. Onkologie. 2011;34:298\u2013303.","journal-title":"Onkologie"},{"key":"850_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7150\/jca.9871","volume":"5","author":"DS Lee","year":"2014","unstructured":"Lee DS, Kim SJ, Kang JH, Hong SH, Jeon EK, Kim YK, et al. Serum carcinoembryonic antigen levels and the risk of whole-body metastatic potential in advanced non-small cell lung cancer. J Cancer. 2014;5:663\u20139.","journal-title":"J Cancer"},{"key":"850_CR22","doi-asserted-by":"publisher","first-page":"e1384108","DOI":"10.1080\/2162402X.2017.1384108","volume":"7","author":"S Ren","year":"2018","unstructured":"Ren S, Zhang S, Jiang T, He Y, Ma Z, Cai H, et al. Early detection of lung cancer by using an autoantibody panel in Chinese population. Oncoimmunology. 2018;7:e1384108.","journal-title":"Oncoimmunology"},{"key":"850_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13019-020-01353-2","volume":"15","author":"A Nasralla","year":"2020","unstructured":"Nasralla A, Lee J, Dang J, Turner S. Elevated preoperative CEA is associated with subclinical nodal involvement and worse survival in stage I non-small cell lung cancer: a systematic review and meta-analysis. J Cardiothorac Surg. 2020;15:318.","journal-title":"J Cardiothorac Surg"},{"key":"850_CR24","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1183\/09031936.97.10081701","volume":"10","author":"RW Light","year":"1997","unstructured":"Light RW, Hamm H. Malignant pleural effusion: would the real cause please stand up? Eur Respir J. 1997;10:1701\u20132.","journal-title":"Eur Respir J"},{"key":"850_CR25","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1148\/radiol.2313030785","volume":"231","author":"GJ Schaffler","year":"2004","unstructured":"Schaffler GJ, Wolf G, Schoellnast H, Groell R, Maier A, Smolle-J\u00fcttner FM, et al. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET. Radiology. 2004;231:858\u201365.","journal-title":"Radiology"},{"key":"850_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39\u201351.","journal-title":"J Thorac Oncol"},{"key":"850_CR27","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1007\/s002590100563","volume":"28","author":"SF Hain","year":"2001","unstructured":"Hain SF, Curran KM, Beggs AD, Fogelman I, O\u2019Doherty MJ, Maisey MN. FDG-PET as a \u201cmetabolic biopsy\u201d tool in thoracic lesions with indeterminate biopsy. Eur J Nucl Med. 2001;28:1336\u201340.","journal-title":"Eur J Nucl Med"},{"key":"850_CR28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/cam4.2770","volume":"9","author":"A Niyonkuru","year":"2020","unstructured":"Niyonkuru A, Chen X, Bakari KH, Wimalarathne DN, Bouhari A, Arnous MMR, et al. Evaluation of the diagnostic efficacy of (18) F-fluorine-2-deoxy-D-glucose PET\/CT for lung cancer and pulmonary tuberculosis in a tuberculosis-endemic country. Cancer Med. 2020;9:931\u201342.","journal-title":"Cancer Med"},{"key":"850_CR29","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2967\/jnumed.118.221770","volume":"60","author":"EC Ehman","year":"2019","unstructured":"Ehman EC, El-Sady MS, Kijewski MF, Khor YM, Jacob S, Ruberg FL, et al. Early detection of multiorgan light-chain amyloidosis by whole-body (18)F-florbetapir PET\/CT. J Nucl Med. 2019;60:1234\u20139.","journal-title":"J Nucl Med"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-021-00850-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-021-00850-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-021-00850-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T20:25:18Z","timestamp":1634329518000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-021-00850-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["850"],"URL":"https:\/\/doi.org\/10.1186\/s13550-021-00850-2","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"18 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were approved by the ethics committee at Shanghai Pulmonary Hospital, Tongji University School of Medicine, and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}